Three-year analysis of Medicare and Medicaid patients compares bariatric surgery to GLP-1 receptor agonists for diabetes management and weight loss outcomes.
3-year real-world comparisonSurgery vs GLP-1 drugs in Medicare and Medicaid diabetes patients
What the researchers found
Three-year comparison of bariatric surgery versus GLP-1 RAs in Medicare and Medicaid patients with diabetes provides real-world effectiveness data in a publicly insured population.
Why it matters
Medicare and Medicaid patients face unique access barriers and disease burdens. Understanding treatment effectiveness in this population guides coverage decisions and equity.
How the study worked
Retrospective 3-year analysis of Medicare and Medicaid claims data comparing outcomes between bariatric surgery and GLP-1 RA treatment in patients with diabetes.
What this study cannot tell us
Retrospective claims analysis — cannot account for all confounders. Selection bias between surgery and medication patients is significant.
How to read the evidence
Retrospective claims analysis — provides real-world effectiveness data but limited by observational design and selection bias.
When this study was published
Published in 2026; reflects current treatment patterns in public insurance.
The bigger picture
As GLP-1 drug coverage expands in public insurance, comparing their real-world value to established bariatric surgery informs healthcare policy and resource allocation.
Questions still open
- Which treatment is more cost-effective over 3 years in publicly insured patients?
- Do outcomes differ between Medicare and Medicaid subpopulations?
Common questions
Is surgery or medication better for weight loss?
Does Medicare cover GLP-1 drugs for weight loss?
Read the original research
Bariatric surgery vs. GLP-1 receptor agonists among primarily medicare and medicaid patients with diabetes: a 3-year analysis.
Surgical endoscopy, 40(1), 671-678
Citation
Brown, Avery; Patel, Suhani S; Li, Elizabeth; Vu, Alexander Hien; Somoza, Eduardo; Chen, Jialin; Zhang, Donglan; Massie, Allan B; Orandi, Babak J; Segev, Dorry; Parikh, Manish; Chhabra, Karan. (2026). Bariatric surgery vs. GLP-1 receptor agonists among primarily medicare and medicaid patients with diabetes: a 3-year analysis.. Surgical endoscopy, 40(1), 671-678. https://doi.org/10.1007/s00464-025-12403-y